| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/26/2011 | CA2415397C Use of strains of parapoxvirus ovis for producing antiviral medicaments and medicaments against cancer |
| 04/26/2011 | CA2386023C Mucosal dtpa vaccines |
| 04/26/2011 | CA2341358C Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor |
| 04/26/2011 | CA2309602C Methods and compositions for enhancing immune response and for the production of in vitro mabs |
| 04/26/2011 | CA2306024C Buccal, polar and non-polar spray or capsule |
| 04/26/2011 | CA2298934C Vectors derived from antibodies for transferring substances into cells |
| 04/26/2011 | CA2289009C Multivalent vaccine composition with mixed carrier |
| 04/26/2011 | CA2201482C Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/21/2011 | WO2011047383A1 Therapeutic combination and methods of treatment with a dll4 antagonist and an anti-hypertensive agent |
| 04/21/2011 | WO2011047346A1 Methods for treating disseminated intravascular coagulation by inhibiting masp-2 dependent complement activation |
| 04/21/2011 | WO2011047340A1 Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine |
| 04/21/2011 | WO2011047328A1 Antibody therapeutics with local activity in the digestive tract |
| 04/21/2011 | WO2011047316A1 Nucleic acid sequences encoding expandable hiv mosaic proteins |
| 04/21/2011 | WO2011047266A1 Il-1 binding proteins |
| 04/21/2011 | WO2011047262A2 Dual variable domain immunoglobulins and uses thereof |
| 04/21/2011 | WO2011047241A1 Enhanced substrates for the protease activity of serotype a botulinum neurotoxin |
| 04/21/2011 | WO2011047180A1 Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereof |
| 04/21/2011 | WO2011047158A1 Isolation of a virus related to canine parvovirus-2 from a raccoon |
| 04/21/2011 | WO2011047153A1 Methods for modulating autoimmunity |
| 04/21/2011 | WO2011047121A1 April antagonists and methods of use |
| 04/21/2011 | WO2011047031A2 Eliciting immune responses using recombinant mva viruses expressing hiv env, gag and pol anitgens |
| 04/21/2011 | WO2011046996A2 Consensus sequence for influenza a virus |
| 04/21/2011 | WO2011046958A1 Use of il-17 receptor a antigen binding proteins |
| 04/21/2011 | WO2011046946A2 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
| 04/21/2011 | WO2011046832A2 Granulysin in immunotherapy |
| 04/21/2011 | WO2011046757A2 Accelerating thrombus resolution through augmentation of p53 activity |
| 04/21/2011 | WO2011046634A1 Infectious clones of torque teno virus |
| 04/21/2011 | WO2011046623A2 Hiv-1 antibodies |
| 04/21/2011 | WO2011046616A2 Methods for modulating bacterial infection |
| 04/21/2011 | WO2011046515A1 Antiproliferative agent |
| 04/21/2011 | WO2011046462A1 Composition for treatment of multiple sclerosis |
| 04/21/2011 | WO2011046457A1 Anti-neoplastic uses of artemin antagonists |
| 04/21/2011 | WO2011045945A1 ANTIBODY RECOGNIZING TURN STRUCTURE IN AMYLOID β |
| 04/21/2011 | WO2011045704A1 Cancer treatment |
| 04/21/2011 | WO2011045573A2 Staphylococcal antigens |
| 04/21/2011 | WO2011045079A1 Hepatitis b virus specific human antibodies |
| 04/21/2011 | WO2011044698A1 Multi epitope vaccine for poultry |
| 04/21/2011 | WO2011025978A3 Methods of treatment using anti-oxidized ldl antibodies |
| 04/21/2011 | WO2011025128A3 Method for treating th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor |
| 04/21/2011 | WO2011022472A3 Methods and compositions for the treatment of proliferative and pathogenic diseases |
| 04/21/2011 | WO2011019134A3 Vaccine composition including salmonella microorganism variants for preventing fowl typhoid |
| 04/21/2011 | WO2011015819A3 Parasite harvesting |
| 04/21/2011 | WO2011011725A3 Use of toxoplasma and derived compositions to prevent or treat microbial infections |
| 04/21/2011 | WO2010147971A3 Il23 modified viral vector for recombinant vaccines and tumor treatment |
| 04/21/2011 | WO2010141093A3 Co-signaling methods for treating cancers |
| 04/21/2011 | WO2010138803A3 Herv-k antigens, antibodies, and methods |
| 04/21/2011 | WO2010138621A3 Diagnosing and treating iga nephropathy |
| 04/21/2011 | WO2010138184A3 Avian derived antibodies |
| 04/21/2011 | WO2010137890A3 Composition for improving the viability and proliferation ability of stem cells |
| 04/21/2011 | WO2010135662A3 Marker differentially expressed in cancer stem cells and methods of using same |
| 04/21/2011 | WO2010135585A3 Engineered type iv pilin of clostridium difficile |
| 04/21/2011 | WO2010135495A3 Stable, spray dried, immunogenic, viral compositions |
| 04/21/2011 | WO2010129457A3 Vaccines against tularemia |
| 04/21/2011 | WO2010124085A3 Compositions and methods for preventing and treating uterine disease |
| 04/21/2011 | WO2010114629A9 Formulation |
| 04/21/2011 | WO2010040508A9 Bispecific anti-vegf/anti-ang-2 antibodies |
| 04/21/2011 | WO2010027501A9 Anti-lipid antibodies |
| 04/21/2011 | WO2008114149A3 Respiratory syncytial virus (rsv) chimeric polypeptide comprising the g protein central region domain located in between the f2 and f1 fusion protein domains |
| 04/21/2011 | WO2008099284A3 Hiv combination vaccine and prime boost method |
| 04/21/2011 | WO2007053489A3 Attenuated salmonella enterica serovar paratyphi a and uses thereof |
| 04/21/2011 | WO2007011411A3 N-fragment of edema factor as an antigen for immunization against anthrax |
| 04/21/2011 | US20110093962 Breast disease targets and uses thereof |
| 04/21/2011 | US20110092961 Artificial cells |
| 04/21/2011 | US20110092674 Non-Functional P2X7 Receptor |
| 04/21/2011 | US20110091881 Mycobacterial genes down-regulated during latency |
| 04/21/2011 | US20110091876 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use |
| 04/21/2011 | US20110091868 Novel antigen constructs useful in the detection and differentiation of antibodies to hiv |
| 04/21/2011 | US20110091565 Method of forming non-immunogenic hydrophobic protein nanoparticles and uses therefor |
| 04/21/2011 | US20110091559 Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof |
| 04/21/2011 | US20110091529 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 04/21/2011 | US20110091528 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 04/21/2011 | US20110091526 Parasite Vaccine |
| 04/21/2011 | US20110091524 Biomarkers for sensitivity to anti-igf1r therapy |
| 04/21/2011 | US20110091508 Oligofluorinated cross-linked polymers and uses thereof |
| 04/21/2011 | US20110091507 Schistosomiasis vaccine compositions and methods of use |
| 04/21/2011 | US20110091506 Vaccine compositions |
| 04/21/2011 | US20110091505 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen |
| 04/21/2011 | US20110091504 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen |
| 04/21/2011 | US20110091503 Therapeutic composition with a botulinum neurotoxin |
| 04/21/2011 | US20110091502 Human parvovirus: humink parvovirus |
| 04/21/2011 | US20110091501 Recombinant Rhinovirus Vectors |
| 04/21/2011 | US20110091500 Inactivated Live-Attenuated Bluetongue Virus Vaccine |
| 04/21/2011 | US20110091499 Treatment of pigs with pcv2 antigent |
| 04/21/2011 | US20110091498 Methods of stimulating an immune response against prostate specific antigen |
| 04/21/2011 | US20110091497 Method For Identifying and Validating Dominant T Helper Cell Epitopes Using An HLA-DM-Assisted Class II Binding Assay |
| 04/21/2011 | US20110091496 Methods and compositions for the delivery of vaccines to disrupted epithelium |
| 04/21/2011 | US20110091495 Hcv e2 construct compositions and methods |
| 04/21/2011 | US20110091494 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |
| 04/21/2011 | US20110091493 Vaccine compositions and uses thereof |
| 04/21/2011 | US20110091492 Escherichia coli immunogens with improved solubility |
| 04/21/2011 | US20110091491 Hiv-1 gp41 neutralization domain and use thereof |
| 04/21/2011 | US20110091490 Novel vaccine for dog |
| 04/21/2011 | US20110091489 Survivin peptide vaccine |
| 04/21/2011 | US20110091488 Water-swellable polymers |
| 04/21/2011 | US20110091487 Melanoma biomarker and methods of uses |
| 04/21/2011 | US20110091486 Inhibition of post-radiation tumor growth |
| 04/21/2011 | US20110091485 Modulation of cell junctions |
| 04/21/2011 | US20110091484 Compositions and methods for preventing or treating a viral infection |
| 04/21/2011 | US20110091483 Canine Anti-CD20 Antibodies |
| 04/21/2011 | US20110091482 Expression of kir in human cancer cells as a biomarker for immuno-escape and cancer metastasis |